Electroencephalography

United States Patent Office Awards Canadian Start-up a Patent to Diagnose Migraine Using Machine Learning

Tuesday, March 2, 2021 - 5:10pm

Scientists have been searching for a brain wave test for migraine for 75 years, but the signals were too complicated to decode until the recent application of machine learning.

Key Points: 
  • Scientists have been searching for a brain wave test for migraine for 75 years, but the signals were too complicated to decode until the recent application of machine learning.
  • U.S. Patent 10,932,725 was issued to Cerebral Diagnostics Canada Incorporated (CDCI) on Tuesday, March 2nd, 2021 by the United States Patent and Trademark Office.
  • It uses signal processing and machine learning to extract thousands of features from the recorded extremely safe electroencephalographic signals.
  • It was derived from Cerebral Diagnostics Canada Inc.
    Our goal is to commercialize starting with an adult test for migraine on headache free days.

Insights on the Epileptic Seizures Treatment Global Market to 2030 - Industry Analysis, Size, Share, Growth, Trends, and Forecasts

Friday, February 26, 2021 - 1:15pm

The report also provides the compound annual growth rate (CAGR) for the global epileptic seizures treatment market for the forecast period.

Key Points: 
  • The report also provides the compound annual growth rate (CAGR) for the global epileptic seizures treatment market for the forecast period.
  • Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global epileptic seizures treatment market.
  • Analysts have employed a combination of top-down and bottom-up approaches to study various phenomena in the global epileptic seizures treatment market.
  • Such valuable insights enable market stakeholders in making informed business decisions for investment in the global epileptic seizures treatment market.

Assure Holdings to Acquire Sentry Neuromonitoring

Thursday, February 25, 2021 - 1:30pm

DENVER, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that effective February 24, 2021, it has signed a Term Sheet (Term Sheet) to acquire (the Acquisition) Sentry Neuromonitoring, LLC (Sentry), one of the largest IONM service providers in Texas, for a purchase price of $3,500,000.

Key Points: 
  • DENVER, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that effective February 24, 2021, it has signed a Term Sheet (Term Sheet) to acquire (the Acquisition) Sentry Neuromonitoring, LLC (Sentry), one of the largest IONM service providers in Texas, for a purchase price of $3,500,000.
  • Under the Term Sheet, Assure will acquire Sentrys contracts, employees, business relationships and assets including accounts receivable, and assume up to $250,000 of its debt.
  • In 2020, Sentry performed more than 5,500 IONM procedures and approximately 50% ofthese procedures were commercial insurance payors.
  • Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.

New Research Highlights the Potential of Transforming Healthcare with Mobile EEG Brain Health Assessments

Tuesday, February 23, 2021 - 6:33pm

The studies explore rapid EEG testing in varied environments, outside of clinical settings, laying the groundwork for the future of brain health.

Key Points: 
  • The studies explore rapid EEG testing in varied environments, outside of clinical settings, laying the groundwork for the future of brain health.
  • The study demonstrated that low-cost mEEG devices both conveniently and accurately measure EEG and human-event related brain potentials (ERPs) that can predict cognitive states like fatigue.
  • "Our work clearly demonstrates that mobile EEG systems can be used to quickly assess the brain state of people in any environment," says Krigolson.
  • "These results suggest a capacity to use mobile EEG technology for brain performance assessments in industry, healthcare, and personal use settings."

New Research Highlights the Potential of Transforming Healthcare with Mobile EEG Brain Health Assessments

Tuesday, February 23, 2021 - 6:16pm

The studies explore rapid EEG testing in varied environments, outside of clinical settings, laying the groundwork for the future of brain health.

Key Points: 
  • The studies explore rapid EEG testing in varied environments, outside of clinical settings, laying the groundwork for the future of brain health.
  • The study demonstrated that low-cost mEEG devices both conveniently and accurately measure EEG and human-event related brain potentials (ERPs) that can predict cognitive states like fatigue.
  • "Our work clearly demonstrates that mobile EEG systems can be used to quickly assess the brain state of people in any environment," says Krigolson.
  • "These results suggest a capacity to use mobile EEG technology for brain performance assessments in industry, healthcare, and personal use settings."

Rhythmlink Receives FDA Clearance for New MR Conditional Electrode Line

Tuesday, February 23, 2021 - 1:00pm

Rhythmlink International, LLC has announced FDA clearance of a new product line.

Key Points: 
  • Rhythmlink International, LLC has announced FDA clearance of a new product line.
  • Sticky Pad Surface Electrodes, a line of peel and stick-on electrodes for Intraoperative Neurophysiological Monitoring (IONM) and Electroencephalography (EEG) are now FDA Cleared MR Conditional for 1.5 and 3 Tesla MRI environments.
  • View the full release here: https://www.businesswire.com/news/home/20210223005148/en/
    MR Conditional Sticky Pads are specially designed for stimulating, recording or grounding.
  • Rhythmlinks original Sticky Pad Electrode line set a new industry benchmark as the only Sticky Pad Electrode to be cleared for both recording and stimulating.

NeuroServo receives certification for its EEG device and for the company as a medical manufacturer

Monday, February 22, 2021 - 3:00pm

MONTREAL, Feb. 22, 2021 /PRNewswire-PRWeb/ --NeuroServo, an early stage medical device company developing an advanced portable and wireless prefrontal EEG announced today that the company received ISO 13485:2016 certification for its R&D and production facilities in Montral.

Key Points: 
  • MONTREAL, Feb. 22, 2021 /PRNewswire-PRWeb/ --NeuroServo, an early stage medical device company developing an advanced portable and wireless prefrontal EEG announced today that the company received ISO 13485:2016 certification for its R&D and production facilities in Montral.
  • This certification is an internationally recognized quality standard to ensure the consistent design, development, production, installation and sale of medical devices that are safe for their intended purposes.
  • In January 2021, NeuroServo received the IEC/EN 60601 and 80601-2-26 certifications for VEEGix, its next-gen EEG.
  • "These are two major milestones for our startup that now becomes a certified medical grade manufacturer with a medical grade device," said Nicolas Tremblay, President.

Psychedelic Partnership Reached, Ehave Inc. and Brain Scientific Sign Memorandum of Understanding to Map Brain Response to Psychedelic Treatment, Collaborate in the Development of Neural Net Algorithms for the Psychedelic Mental Health Sector, E-Tattoo Te

Wednesday, February 17, 2021 - 1:30pm

This same functional lab can be used to study consumer behavior and psychology in markets Ehave operates for further commercialization of Ehaves data and technologies.

Key Points: 
  • This same functional lab can be used to study consumer behavior and psychology in markets Ehave operates for further commercialization of Ehaves data and technologies.
  • Brain Scientific is seeking to improve neurology by modernizing the brain diagnostic market with its cutting-edge technology.
  • As part of the MoU, Brain Scientific would provide its proprietary data signal acquisition devices, NeuroCap and NeuroEEG, for the Ehave platform.
  • All data from any transactions contemplated by the MoU will be jointly owned by both Ehave and Brain Scientific.

JAMA Highlights Success of BrainScope's EEG-based Concussion Index As Reliable Indicator of Concussion

Tuesday, February 16, 2021 - 12:45pm

Specific variables from the multi-modal assessment were used to generate a Concussion Index at each time point, with EEG having the largest contribution.

Key Points: 
  • Specific variables from the multi-modal assessment were used to generate a Concussion Index at each time point, with EEG having the largest contribution.
  • The study was conducted between 2017 to 2019 with referrals from 49 high schools, colleges, and concussion clinics in the US.
  • The Concussion Index had a sensitivity of 86%, specificity of 71%, and negative predictive value of 90%.
  • These results support the high accuracy of the Concussion Index in the identification of the likelihood of concussion, with performance above that reported in the literature for concussion assessment tools, which are largely subjective and show poor replicability.

Leading Health Institute Partners with Innovative Brain Optimization Company

Monday, February 15, 2021 - 1:55pm

Flowers Health Institute to provide comprehensive brain function assessment through best-in-class, deepbrain mappingfor all patients.

Key Points: 
  • Flowers Health Institute to provide comprehensive brain function assessment through best-in-class, deepbrain mappingfor all patients.
  • Flowers Health Institute, located in Houston, Texas,is comprised of high-end medical facilities, with access to the largest medical campus in the world.
  • Neurologics brain maps lay the groundwork for qEEG-powered interactive brain optimization programs, customized to each patient'sbrain.
  • Flowers Health Institute specializes in providing comprehensive health and wellness evaluations for individuals who want to improve their quality of life.